Johnson & Johnson has submitted the final manufacturing data needed for Health Canada to make a decision on approving its COVID-19 vaccine. Unlike those currently approved for use in Canada, it is administered as a single shot. Health Canada’s chief medical advisor, Dr. Supriya Sharma, estimates that review of the data could take approximately two weeks.